SCHEMBL4941553

SCHEMBL4941553

COc1cc(OC)c(S(=O)(=O)N2CCCCC2)cc1-c1nnc(O)n1-c1ccccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
TSHR P16473 5/20 0.50
GAA P10253 2/20 0.50
NPBWR1 P48145 1/20 0.50
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 2/20 0.46
MCOLN3 Q8TDD5 1/20 0.46
POLB P06746 1/20 0.46
LMNA P02545 5/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 3/20 0.43
MEN1 O00255 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CNR2 P34972 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940708 0.92 MAPT (0.50) ALDH1A1TSHRGAAKMT2ARAB9A
SCHEMBL14116738 0.90 TSHR (0.52) ALDH1A1TSHRGAANPBWR1KMT2A
SCHEMBL13472999 0.86 HSP90AA1 (0.39) ALDH1A1TSHRGAAPOLBLMNA
SCHEMBL14116737 0.86 HSP90AA1 (0.39) ALDH1A1TSHRGAAKMT2APOLB
SCHEMBL4940502 0.84 HSP90AA1 (0.47) ALDH1A1TSHRGAAKDM4ELMNA
SCHEMBL4943504 0.81 ALPL (0.44) ALDH1A1TSHRSMN1; SMN2MAPTNPC1
SCHEMBL4942328 0.81 TSHR (0.41) ALDH1A1TSHRGAAKMT2AKDM4E
SCHEMBL4937213 0.80 HSP90AA1 (0.41) ALDH1A1TSHRGAAKMT2ARAB9A
SCHEMBL1628804 0.77 TSHR (0.52) ALDH1A1TSHRGAANPBWR1KMT2A
SCHEMBL4941311 0.77 HSP90AA1 (0.48) ALDH1A1TSHRGAAKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 ALDH1A1 1580/4885TSHR 1164/4885GAA 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.